Figure 1.

(a) Expression of MUC1 with sialoglycans detected by monoclonal antibody (mAb) MY.1E12 in an ovarian clear cell adenocarcinoma specimen. Both solid lesions and papillary lesions showed sialylated MUC1 expression on the apical membrane and the cytoplasm. (b) Relationship between sialylated MUC1 expression and survival of patients with clear cell adenocarcinoma. All patients were divided into two groups: low score (≤ +) and high score (≥ ++). (c) Frequency analysis of mAb MY.1E12 binding in clear cell adenocarcinoma of the ovary according to stage. The number of patients is given in parentheses.